Apellis Pharmaceuticals, Inc. (APLS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
17/25
Growth 5
Margin 4
Expansion 4
Platform 2
Financial 2
latest quarter score
Earnings Reports
- 17
- 10
- 13